Therapeutic Applications of Computational Biology and Chemistry: TACBAC 2010

With the US National Institute of Health’s Molecular Library Initiative and the EMBL-European Bioinformatics Institute’s chemogenomics and cheminformatics programmes, large-scale drug discovery and biological screening data have entered the public domain. We are also witnessing the first efforts to sequence individual human genomes, and are making impressive progress in understanding the genomes of some of the world’s most significant disease-causing organisms. Integration of genomic sequence information with proteomics and metabolomics data provides an unprecedented chance to systematically attack disease on a molecular level. Open access to bioinformatics and cheminformatics data also opens up exciting new opportunities for academic–industrial collaboration. TACBAC 2010 will bring together experts from both the biomedical and the computational domains to explore these novel developments, discuss how to overcome the major challenges, and create new opportunities for applying computational biology and chemistry to disease management and prevention.

Locations